OncologyLink

insights & foresights for strategic decisions™

rigorous | responsible | relevant™ 

OncologyLink provides knowledge-based actionable intelligence that is rigorous, responsible and relevant to decision making for investment in cancer therapeutics, diagnostics and theranostics.


what we do


Our due diligence support includes cancer therapeutics, diagnostics and theranostics coverage by molecular targets, mechanism of action, biomarkers, clinical genomics, clinical indications, R&D pipelines, and technology platforms.

  • comprehensive competitive landscape evaluations customized to meet the need of clients 
  • visually appealing deliverables that reveal trends and scenarios to guide further action, implementation and integration into corporate strategy


clientele


  • Pharmaceutical, biotechnology and diagnostic companies
  • Pharmacogenomics (PGx), pharmacoepigenomics and companion diagnostic (CDx) firms
  • Healthcare industries  with focus on personalized medicine
  • Investors - private and public

​​

end-users


  • Business development teams
  • Product development, marketing and sales teams
  • Technology transfer and intellectual asset management
  • Clinical development teams and clinicians
  • Drug discovery and product R&D leadership
  • Legal, medical and regulatory affairs teams
  • Start-ups seeking financing, licensing or acquisition opportunities
  • Bio-Investors, VC firms, funding agencies and other stakeholders
Cancer therapeutics and diagnostics 

Copyright © 2009-2014 OncologyLink LLC | All rights reserved